Works matching IS 03407004 AND DT 2010 AND VI 59 AND IP 10
Results: 19
DNA vaccination strategies for anti-tumour effective gene therapy protocols.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1583, doi. 10.1007/s00262-010-0853-x
- By:
- Publication type:
- Article
CD8+ T cell recognition of polymorphic wild-type sequence p53<sub>65–73</sub> peptides in squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1561, doi. 10.1007/s00262-010-0886-1
- By:
- Publication type:
- Article
The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1503, doi. 10.1007/s00262-010-0877-2
- By:
- Publication type:
- Article
Response to the letter to the editors by Ottaiano et al.: “Cetuximab-dependent ADCC in cancer: dream or reality?”.
- Published in:
- 2010
- By:
- Publication type:
- Letter
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1601, doi. 10.1007/s00262-010-0893-2
- By:
- Publication type:
- Article
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1551, doi. 10.1007/s00262-010-0882-5
- By:
- Publication type:
- Article
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1573, doi. 10.1007/s00262-010-0833-1
- By:
- Publication type:
- Article
Ninth international conference on progress in vaccination against cancer (PIVAC 9), 8–10 October 2009, Sofia, Bulgaria.
- Published in:
- 2010
- By:
- Publication type:
- Report
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1593, doi. 10.1007/s00262-010-0855-8
- By:
- Publication type:
- Article
A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1531, doi. 10.1007/s00262-010-0880-7
- By:
- Publication type:
- Article
Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1457, doi. 10.1007/s00262-010-0868-3
- By:
- Publication type:
- Article
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1467, doi. 10.1007/s00262-010-0871-8
- By:
- Publication type:
- Article
Identification and characterization of Ch806 mimotopes.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1481, doi. 10.1007/s00262-010-0872-7
- By:
- Publication type:
- Article
Response definition criteria for ELISPOT assays revisited.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1489, doi. 10.1007/s00262-010-0875-4
- By:
- Publication type:
- Article
Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1449, doi. 10.1007/s00262-010-0873-6
- By:
- Publication type:
- Article
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1521, doi. 10.1007/s00262-010-0879-0
- By:
- Publication type:
- Article
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1511, doi. 10.1007/s00262-010-0878-1
- By:
- Publication type:
- Article
CD8<sup>+</sup> tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1543, doi. 10.1007/s00262-010-0881-6
- By:
- Publication type:
- Article
Cetuximab-dependent ADCC in cancer: dream or reality?
- Published in:
- 2010
- By:
- Publication type:
- Letter